This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
6 - 8 June, 2023
Postillon Hotel AmsterdamDigital Experience: All Sessions Live-streamed 6-8 June, 2023

Peter Slavny, PhD
Chief Technology Officer at Iontas Ltd.

Profile

Peter received a PhD in biochemistry from the John Innes Centre in Norwich, UK. He subsequently joined the McCafferty laboratory at the University of Cambridge, UK, as a post-doctoral researcher working on therapeutic antibody discovery by phage display. He was a co-founder of IONTAS ltd in 2012, where he worked as a Project Leader running successful antibody discovery campaigns to diverse, often challenging, target classes. He is currently Chief Technology Officer at IONTAS overseeing antibody discovery and engineering.

Agenda Sessions

  • Beyond Affinity: Final Format Biologics Discovery, Optimisation and Developability Screening from Mammalian Display Libraries

    14:35